Trial
NCT02466568
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Lung Cancer
Intervention
Nivolumab
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-09